Our research group is based at Karolinska University Hospital and ̽»¨¾«Ñ¡ and consists of clinically active physicians with specialist expertise in pediatric oncology, pediatric neurology and coagulation. The group's common goal is to improve the treatment and quality of life of children with cancer or hemophilia by increasing knowledge about treatment-related complications, and by refining diagnostics for bleeding disorders.
Susanna Ranta is a senior consultant in pediatric oncology and coagulation at Karolinska University Hospital and team leader of the Pediatric Cancer Research Unit at ̽»¨¾«Ñ¡.
Her research focuses on toxicity during and after treatment of childhood leukemia, with the goal of reducing acute and long-term side effects. She is currently leading BRAIN-Sweden, a national study on acute neurotoxicity and late cognitive side effects after leukemia treatment. She is also involved in research on hemostasis in children with cancer, especially leukemia, and in children with hemophilia.
Stavroula Anastasopoulou is a senior physician in the pediatric neurology department at Astrid Lindgren's Children's Hospital. She researches how cancer affects the central nervous system in children and adolescents, as well as the clinical consequences of epilepsy.
Cristina Egnell is a specialist in pediatric hematology and oncology at Astrid Lindgren's Children's Hospital, Karolinska University Hospital. She conducts research into various treatment-related complications of childhood leukemia.
David Schmidt's research focuses on diagnostic accuracy studies in coagulopathies and platelet disorders, clinical and molecular prognosis in childhood immune thrombocytopenia, as well as the use of statistical learning and penalized regression (LASSO, ridge, Elastic Net).
Hans Hemmingsson is a specialist in pediatric hematology and oncology, pediatric oncologist, Astrid Lindgren's Children's Hospital, Karolinska University Hospital with expertise in coagulation. PhD student in the BRAIN-Sweden project.